Operating Licence Application: Seven Documents and a Forty-Five Working Day Decision
Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
The Panamanian operating licence application rests on seven items listed in Article 17 of Decreto Ejecutivo N° 490 as amended by Article 1 of Decreto Ejecutivo N° 416, which reduced the list from eight to seven: the application form, a simple copy of the legal representative’s identity document, a simple copy of the public registry certificate issued within the preceding three months, a sworn statement, a sketch or map showing the location of the premises, a list of the devices intended to be handled, and proof of payment, with item seven waived for Panamanian public institutions. The statutory decision period is no more than forty-five working days under Article 20, with a further forty-five working days where corrections are required; a file not completed in that period is treated as withdrawn and must be filed afresh.
Two features of this file deserve attention before any document is prepared. The list is closed: the amendment removed the catch-all item that had allowed the regulator to add requirements by regulation. And the sworn statement is not a formality attached to the pack but the instrument through which every other statement becomes legally attributable to the signatory, while also authorising present and future inspection.
- Seven items, not eight — the eighth item of the original Article 17 was deleted by Article 1 of DE 416, so citing the article without noting the amendment misstates the file.
- Public registry certificate — issued within the preceding three months, with DE 416 adding the qualifier cuando aplique.
- Sworn statement — certifies that all information and documentation supplied is true and authorises current or future inspection by DNDM.
- Location sketch — a plan or map of the premises, preferably with coordinates, which inspectors later test against reality.
- Device list — the devices and related products already sold and/or intended to be sold, signed by the legal representative or agent.
- Proof of payment — required except for Panamanian public institutions, expressly exempted from item seven.
- Forty-five plus forty-five working days — the decision and correction periods are separate allowances, and expiry of the second is treated as withdrawal.
2. Legal basis
Article 17 of DE 490 sets out the documentary requirements and was amended by Article 1 of Decreto Ejecutivo N.º 416 of 13 May 2020, whose final sentence exempts Panamanian public institutions from item seven. Article 19 confers inspection powers, Article 20 governs timing and withdrawal, and Article 18 permits delegation of activities to third parties subject to conditions.
| Decreto Ejecutivo N° 490 (4 October 2019) | Article 17 (as amended by Article 1 of DE 416) | Documents: 1. application form signed by the legal representative or an agent duly empowered by notarial or public registry mandate, stating the application type; 2. simple copy of the identity card or passport of the legal representative or agent; 3. simple copy of the public registry certificate, issued within the preceding three months (DE 416 adds cuando aplique); 4. sworn statement signed by the authorised representative declaring that all information is true, in the standard format, authorising present or future inspection by DNDM; 5. sketch or map of the premises, preferably with coordinates; 6. list of devices and/or related products sold and/or to be sold, signed by the representative or agent; 7. proof of payment (comprobante de pago) |
| Decreto Ejecutivo N.º 416 (13 May 2020) | Article 1, final sentence | Para las Instituciones Públicas de la República de Panamá se exceptúa el numeral 7 |
| Decreto Ejecutivo N° 490 | Original Article 17, item 8 | Otros requisitos que la Dirección Nacional de Dispositivos Médicos establezca mediante reglamentación — deleted by DE 416 |
| Decreto Ejecutivo N° 490 | Article 19 | DNDM may inspect premises, ex officio or without prior notice, on complaint, suspicion, vigilance report, incident or failure; an inspection record must be prepared and a copy delivered to personnel on site |
| Decreto Ejecutivo N° 490 | Article 20 | Applications and their updates, renewals and corrections decided within 45 working days of proof of compliance; refusal or return must be reasoned in writing; further 45 working days for additional information or corrections; expiry treated as withdrawal, with the file returned and a fresh application permitted |
| Decreto Ejecutivo N° 490 | Article 18 | Manufacturing, conditioning and distribution premises may delegate activities to third parties on submission of a notarised contract copy and disclosure of the third party’s address in the application and sworn statement; the third party is subject to DNDM inspection; conditioning applications require the manufacturer authorisation |
3. Expert insights
Insight one: DE 416 reduced the file from eight items to seven by deleting a catch-all clause. The original item 8 read otros requisitos que la Dirección Nacional de Dispositivos Médicos establezca mediante reglamentación, an open-ended provision allowing further requirements to be created below the level of the decree. DE 416 removed it, added cuando aplique to item 3 and exempted public institutions from the payment proof. The direction of travel is a closed list and less administrative discretion, so the seven items are exhaustive and cannot be supplemented by informal request.
Insight two: the sworn statement in item 4 anchors every later compliance obligation. The text requires the signatory to certify that all information and documentation provided is true (certificar que toda la información y documentación proporcionada es veraz) and to authorise current or future inspection. Article 33 ties all declared information back to that statement, and a breach of the truth requirement can lead to suspension or cancellation of the CCT or the operating licence; Article 69, item 4, lists failure to honour commitments in the sworn statement as a ground for licence suspension. It should therefore be reviewed by the person able to verify each fact, not signed as a formality.
Insight three: the inspection power in Article 19 is broad and may be exercised without notice. The article sets out six triggers: ex officio action, a complaint, a suspicion, a vigilance report, a device incident, or a failure. It expressly provides for inspection sin previo aviso, and requires an acta to be drawn up and a copy handed to the personnel present. This shifts the emphasis from preparing for an announced visit to keeping the premises inspectable at all times.
Insight four: Article 18 allows delegation to a third party, but responsibility does not move with the activity. Manufacturing, conditioning and distribution premises may entrust operations to a third party provided that a notarised copy of the contract is filed, the third party’s address is declared in the application and the sworn statement, and the third party accepts inspection by DNDM. The final sentence is decisive: El representante legal de quien solicite la licencia es quien tendrá la responsabilidad directa ante la DNDM. Outsourcing the warehouse does not outsource the liability.
4. Practical recommendations
- Prepare against the seven-item list as amended by DE 416, and retire any internal template that still reflects the original eight-item version.
- Track the issue date of the public registry certificate and renew it if it will be older than three months at filing.
- Use the standard DNDM format for the sworn statement and have it signed by a person with proper authority and access to the underlying records.
- Maintain the premises to an always-inspectable standard, and file every inspection record received, since the acta is the reference document in any later dispute.
- Where activities are delegated, complete all three conditions together: notarised contract, declared address, third-party acceptance of inspection, and define internal responsibility for the delegated site in writing.
- Diarise the forty-five working day decision point and the separate forty-five working day correction window, so that a returned file is answered well inside the second period.
5. Verification checklist
- □ File assembled against the seven-item list as amended by DE 416
- □ Public registry certificate issued within the preceding three months
- □ Sworn statement in the standard format and expressly authorising inspection
- □ Location sketch or map includes coordinates
- □ Device list signed by the legal representative or authorised agent
- □ Proof of payment attached, or the public institution exemption documented
- □ Forty-five working day decision point and correction window both tracked
- □ Delegated activities supported by notarised contract and declared address (Article 18)
How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Panamanian market. Our team manages Ministry of Health (MINSA) sanitary registration applications, prepares Spanish-language dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us